FDA Inspection
Vaughn, Silverberg and Associates, LLPFDA Inspection 1149752 - Vaughn, Silverberg and Associates, LLP - August 23, 2021
Record Details
This FDA Inspection record concerns Vaughn, Silverberg and Associates, LLP, with an inspection on August 23, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 23, 2021
- Product Type
- Biologics
View Company Profile
ID · 827d1d8b-f9b7-40f8-801b-8dc86361b774
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1149752
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Vaughn, Silverberg and Associates, LLP
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 19, 2025 | Not classified | Dallas District Office | |
| March 29, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 19, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 22, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 7, 2008 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Vaughn, Silverberg and Associates, LLP
- FDA Inspection 1262041 - 2025-02-19
- FDA Inspection 1049715 - 2018-03-29
- FDA Inspection 887828 - 2014-07-19
- FDA Inspection 773428 - 2012-03-22
- FDA Inspection 541693 - 2008-10-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.